Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
and D.H
How to set goals and track progress with your clinician Setting goals with your clinician can help make your weight-management efforts more effective and sustainable
Clinical Trial Insights In SURMOUNT-1 and SURPASS trials, Mounjaro showed: Up to 22.5% body weight reduction in non-diabetic obese patients Greater HbA1c reductions vs Ozempic and insulin in diabetics Reference : Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Reference : mounjaro.lilly.com/hcp/a1c-weight FDA approved Mounjaro for Type 2 Diabetes in 2022, and later for weight loss under the brand Zepbound in Nov 2023 (US)
Fiber Complexes : Aid digestion and support GLP-1 response in the gut
Gym access is ideal but not required
US$ 21.32
US$ 25.47
US$ 25.57
US$ 25.12
US$ 25.29
US$ 26.06
.jpg)
US$ 24.45
